OpenURL Connection Search

Select item for more details and to access through your institution.

The influence of CRS and ICANS on the efficacy of anti-CD19 CAR-T treatment for B-cell acute lymphoblastic leukemia.
Published in:
Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1448709
By:
- Yuhan Ma;
- Hongyuan Zhou;
- Jiaoli Zhang;
- Qing Zhang;
- Yujie Li;
- Ruiyang Xie;
- Bingpei Zhang;
- Ziyuan Shen;
- Ping Li;
- Aibin Liang;
- Keshu Zhou;
- Lu Han;
- Yongxian Hu;
- Kailin Xu;
- Wei Sang;
- Xiangmin Wang
Publication type:
Article
Treatment of relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma with the BTK inhibitor zanubrutinib: phase 2, single-arm, multicenter study.
Published in:
Journal of Hematology & Oncology, 2020, v. 13, n. 1, p. 1, doi. 10.1186/s13045-020-00884-4
By:
- Xu, Wei;
- Yang, Shenmiao;
- Zhou, Keshu;
- Pan, Ling;
- Li, Zengjun;
- Zhou, Jianfeng;
- Gao, Sujun;
- Zhou, Daobin;
- Hu, Jianda;
- Feng, Ru;
- Huang, Haiwen;
- Ji, Meng;
- Guo, Haiyi;
- Huang, Jane;
- Novotny, William;
- Feng, Shibao;
- Li, Jianyong
Publication type:
Article
Selection of hematopoietic stem cell transplantation for T-cell lymphoblastic lymphoma.
Published in:
Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1193237
By:
- Zhen Li;
- Binglei Zhang;
- Xinxin Fan;
- Ruirui Gui;
- Fengkuan Yu;
- Juan Wang;
- Yanli Zhang;
- Keshu Zhou;
- Yanyan Liu;
- Yufu Li;
- Jing Ding;
- Yongping Song;
- Jian Zhou
Publication type:
Article
A retrospective study of autologous hematopoietic stem cell transplantation for peripheral T-cell lymphoma: pre-transplant patients with partial remission benefit from post-transplant maintenance therapy.
Published in:
Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1162413
By:
- Zhenghua Huang;
- Zhen Li;
- Juan Wang;
- Ruirui Gui;
- Yingling Zu;
- Fengkuan Yu;
- Quande Lin;
- Huifang Zhao;
- Yanli Zhang;
- Baijun Fang;
- Yanyan Liu;
- Keshu Zhou;
- Yufu Li;
- Yuewen Fu;
- Zhihua Yao;
- Yongping Song;
- Jian Zhou
Publication type:
Article
Reshaping the tumor microenvironment: The versatility of immunomodulatory drugs in B-cell neoplasms.
Published in:
Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.1017990
By:
- Hao Guo;
- Jingyi Yang;
- Haoran Wang;
- Xingchen Liu;
- Yanyan Liu;
- Keshu Zhou
Publication type:
Article
Case Report: Successful engraftment of allogeneic hematopoietic stem cells using CAR-T cell therapy as the conditioning regimen in R/R Ph+ B cell acute lymphoblastic leukemia.
Published in:
Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.965932
By:
- Lu Han;
- Ran Zhao;
- Jingyi Yang;
- Yingling Zu;
- Yanyan Liu;
- Jian Zhou;
- Linlin Li;
- Zhenghua Huang;
- Jishuai Zhang;
- Quanli Gao;
- Yongping Song;
- Keshu Zhou
Publication type:
Article
Nasal and cutaneous mucormycosis in two patients with lymphoma after chemotherapy and target therapy: Early detection by metagenomic next-generation sequencing.
Published in:
Frontiers in Cellular & Infection Microbiology, 2022, v. 12, p. 1, doi. 10.3389/fcimb.2022.960766
By:
- Qing Zhang;
- Xingchen Liu;
- Yanyan Liu;
- Huiqin Wang;
- Ran Zhao;
- Xiaodong Lv;
- Xudong Wei;
- KeShu Zhou
Publication type:
Article
Indirect comparisons of efficacy of zanubrutinib versus orelabrutinib in patients with relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma or relapsed or refractory mantle cell lymphoma.
Published in:
Investigational New Drugs, 2023, v. 41, n. 4, p. 606, doi. 10.1007/s10637-023-01376-1
By:
- Song, Yuqin;
- Zhou, Keshu;
- Yang, Shenmiao;
- Hu, Jianda;
- Zou, Dehui;
- Gao, Sujun;
- Pan, Ling;
- Wang, Tingyu;
- Yang, Haiyan;
- Zhang, Huilai;
- Zhou, Daobin;
- Ji, Jie;
- Xu, Wei;
- Feng, Ru;
- Jin, Jie;
- Lv, Fangfang;
- Huang, Haiwen;
- Fan, Xiaosi;
- Xu, Sheng;
- Zhu, Jun
Publication type:
Article
Orelabrutinib for the treatment of relapsed or refractory marginal zone lymphoma: A phase 2, multicenter, open‐label study.
Published in:
American Journal of Hematology, 2023, v. 98, n. 11, p. 1742, doi. 10.1002/ajh.27064
By:
- Deng, Lijuan;
- Li, Zhiming;
- Zhang, Huilai;
- Huang, Haiwen;
- Hu, Jianda;
- Liu, Lihong;
- Liu, Ting;
- Jin, Jie;
- Zhu, Zunmin;
- Li, Wenyu;
- Huang, Zhenqian;
- Huang, Wenrong;
- Zhou, Keshu;
- Yang, Haiyan;
- Zhang, Mingzhi;
- Ding, Kaiyang;
- Zhou, Hui;
- Hu, Yu;
- Shuang, Yuerong;
- Cao, Junning
Publication type:
Article
Orelabrutinib in relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma patients: Multi‐center, single‐arm, open‐label, phase 2 study.
Published in:
American Journal of Hematology, 2023, v. 98, n. 4, p. 571, doi. 10.1002/ajh.26826
By:
- Xu, Wei;
- Zhou, Keshu;
- Wang, Tingyu;
- Yang, Shenmiao;
- Liu, Lihong;
- Hu, Yu;
- Zhang, Wei;
- Ding, Kaiyang;
- Zhou, Jianfeng;
- Gao, Sujun;
- Xu, Bing;
- Zhu, Zunmin;
- Liu, Ting;
- Zhang, Huilai;
- Hu, Jianda;
- Ji, Chunyan;
- Wang, Shunqing;
- Xia, Zhongjun;
- Wang, Xin;
- Li, Yan
Publication type:
Article
Improved efficacy and safety of zanubrutinib versus ibrutinib in patients with relapsed/refractory chronic lymphocytic leukemia (R/R CLL) in China: a subgroup of ALPINE.
Published in:
Annals of Hematology, 2024, v. 103, n. 10, p. 4183, doi. 10.1007/s00277-024-05823-8
By:
- Zhou, Keshu;
- Wang, Tingyu;
- Pan, Ling;
- Xu, Wei;
- Jin, Jie;
- Zhang, Wei;
- Hu, Yu;
- Hu, Jianda;
- Feng, Ru;
- Li, Ping;
- Liu, Zhougang;
- Liu, Peng;
- Jing, Hongmei;
- Gao, Sujun;
- Zhang, Huilai;
- Yu, Kang;
- Wang, Zhao;
- Zhu, Xiongpeng;
- Sun, Zimin;
- Li, Fei
Publication type:
Article
Culturing adequate CAR-T cells from less peripheral blood to treat B-cell malignancies.
Published in:
Community Practitioner, 2021, v. 94, n. 6, p. 1066, doi. 10.20892/j.issn.2095-3941.2021.0040
By:
- Lu Han;
- Jian Zhou;
- Linlin Li;
- Keshu Zhou;
- Lingdi Zhao;
- Xinghu Zhu;
- Qingsong Yin;
- Yufu Li;
- Hongqin You;
- Jishuai Zhang;
- Yongping Song;
- Quanli Gao
Publication type:
Article
Long‐term outcomes of second‐line versus later‐line zanubrutinib treatment in patients with relapsed/refractory mantle cell lymphoma: An updated pooled analysis.
Published in:
Cancer Medicine, 2023, v. 12, n. 18, p. 18643, doi. 10.1002/cam4.6473
By:
- Song, Yuqin;
- Zhou, Keshu;
- Zou, Dehui;
- Li, Dengju;
- Hu, Jianda;
- Yang, Haiyan;
- Zhang, Huilai;
- Ji, Jie;
- Xu, Wei;
- Jin, Jie;
- Lv, Fangfang;
- Feng, Ru;
- Gao, Sujun;
- Zhou, Daobin;
- Tam, Constantine S.;
- Simpson, David;
- Wang, Michael;
- Phillips, Tycel J.;
- Opat, Stephen;
- Fang, Cheng
Publication type:
Article
Culturing adequate CAR-T cells from less peripheral blood to treat B-cell malignancies.
Published in:
Cancer Biology & Medicine, 2021, v. 18, n. 4, p. 1066, doi. 10.20892/j.issn.2095-3941.2021.0040
By:
- Lu Han;
- Jian Zhou;
- Linlin Li;
- Keshu Zhou;
- Lingdi Zhao;
- Xinghu Zhu;
- Qingsong Yin;
- Yufu Li;
- Hongqin You;
- Jishuai Zhang;
- Yongping Song;
- Quanli Gao
Publication type:
Article
First interim analysis of alpine study: results of a phase 3 randomized study of zanubrutinib vs. ibrutinib in patients with relapsed/refractory (R/R) chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL).
Published in:
Acta Haematologica Polonica, 2022, v. 53, n. A, p. 32
By:
- Jurczak, Wojciech;
- Eichhorst, Barbara;
- Brown, Jennifer J.;
- Lamanna, Nicole;
- O'Brien, Susan;
- Tam, Constantine S.;
- Lugui Qiu;
- Kazmierczak, Maciej;
- Zhou, Keshu;
- Šimkovič, Martin;
- Mayer, Jiri;
- Gillespie-Twardy, Amanda;
- Shadman, Mazyar;
- Ferrajoli, Alessandra;
- Ganly, Peter S.;
- Weinkove, Robert;
- Salmi, Tommi;
- Wu, Kenneth;
- Novotny, William;
- Hillmen, Peter
Publication type:
Article
The resistance mechanisms and treatment strategies of BTK inhibitors in B‐cell lymphoma.
Published in:
Hematological Oncology, 2021, v. 39, n. 5, p. 605, doi. 10.1002/hon.2933
By:
- Wang, Haoran;
- Zhang, Wentao;
- Yang, Jingyi;
- Zhou, Keshu
Publication type:
Article
Dual-targeted CAR T-cell immunotherapies for hematological malignancies: latest updates from the 2023 ASH annual meeting.
Published in:
Experimental Hematology & Oncology, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40164-024-00485-8
By:
- Yang, Jingyi;
- Guo, Hao;
- Han, Lu;
- Song, Yongping;
- Zhou, Keshu
Publication type:
Article
Bruton tyrosine kinase inhibitors in B-cell lymphoma: beyond the antitumour effect.
Published in:
Experimental Hematology & Oncology, 2022, v. 11, n. 1, p. 1, doi. 10.1186/s40164-022-00315-9
By:
- Wang, Haoran;
- Guo, Hao;
- Yang, Jingyi;
- Liu, Yanyan;
- Liu, Xingchen;
- Zhang, Qing;
- Zhou, Keshu
Publication type:
Article
Chimeric antigen receptor T-cell therapy for relapsed and refractory thyroid cancer.
Published in:
Experimental Hematology & Oncology, 2022, v. 11, n. 1, p. 1, doi. 10.1186/s40164-022-00311-z
By:
- Ding, Jing;
- Li, Deyu;
- Liu, Xingchen;
- Hei, Hu;
- Sun, Baoxi;
- Zhou, Dongmin;
- Zhou, Keshu;
- Song, Yongping
Publication type:
Article
Penpulimab for Relapsed or Refractory Classical Hodgkin Lymphoma: A Multicenter, Single-Arm, Pivotal Phase I/II Trial (AK105-201).
Published in:
Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.925236
By:
- Yuqin Song;
- Keshu Zhou;
- Chuan Jin;
- Zhengzi Qian;
- Ming Hou;
- Lei Fan;
- Fei Li;
- Kaiyang Ding;
- Hui Zhou;
- Xiaoling Li;
- Bing Chen;
- Xiuhua Sun;
- Xianmin Song;
- Ming Jiang;
- Qingyuan Zhang;
- Lihong Liu;
- Guohua Yu;
- Yu Hu;
- Zheng Zhao;
- Ligen Liu
Publication type:
Article
The influence of CRS and ICANS on the efficacy of anti-CD19 CAR-T treatment for B-cell acute lymphoblastic leukemia.
Published in:
Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1448709
By:
- Yuhan Ma;
- Hongyuan Zhou;
- Jiaoli Zhang;
- Qing Zhang;
- Yujie Li;
- Ruiyang Xie;
- Bingpei Zhang;
- Ziyuan Shen;
- Ping Li;
- Aibin Liang;
- Keshu Zhou;
- Lu Han;
- Yongxian Hu;
- Kailin Xu;
- Wei Sang;
- Xiangmin Wang
Publication type:
Article
The influence of CRS and ICANS on the efficacy of anti-CD19 CAR-T treatment for B-cell acute lymphoblastic leukemia.
Published in:
Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1448709
By:
- Yuhan Ma;
- Hongyuan Zhou;
- Jiaoli Zhang;
- Qing Zhang;
- Yujie Li;
- Ruiyang Xie;
- Bingpei Zhang;
- Ziyuan Shen;
- Ping Li;
- Aibin Liang;
- Keshu Zhou;
- Lu Han;
- Yongxian Hu;
- Kailin Xu;
- Wei Sang;
- Xiangmin Wang
Publication type:
Article
Aberrant histone modification in CD19<sup>+</sup> B cells of patients with chronic lymphocytic leukemia.
Published in:
OncoTargets & Therapy, 2017, v. 10, p. 1173, doi. 10.2147/OTT.S121301
By:
- Keshu Zhou;
- Qing Zhang;
- Yanyan Liu;
- Yuanyuan Xiong;
- Shengsheng Wu;
- Jingke Yang;
- Hu Zhou;
- Xinjian Liu;
- Xudong Wei;
- Yongping Song
Publication type:
Article
Zanubrutinib monotherapy in relapsed/refractory mantle cell lymphoma: a pooled analysis of two clinical trials.
Published in:
Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-021-01174-3
By:
- Zhou, Keshu;
- Zou, Dehui;
- Zhou, Jianfeng;
- Hu, Jianda;
- Yang, Haiyan;
- Zhang, Huilai;
- Ji, Jie;
- Xu, Wei;
- Jin, Jie;
- Lv, Fangfang;
- Feng, Ru;
- Gao, Sujun;
- Zhou, Daobin;
- Tam, Constantine S.;
- Simpson, David;
- Wang, Michael;
- Phillips, Tycel J.;
- Opat, Stephen;
- Huang, Zhiyue;
- Lu, Huafei
Publication type:
Article
Impact of tocilizumab on anti‐CD19 chimeric antigen receptor T‐cell therapy in B‐cell acute lymphoblastic leukemia.
Published in:
Cancer (0008543X), 2024, v. 130, n. 15, p. 2660, doi. 10.1002/cncr.35316
By:
- Wang, Xiangmin;
- Zhang, Bingpei;
- Zhang, Qing;
- Zhou, Hongyuan;
- Sun, Qian;
- Zhou, Yi;
- Li, Tianci;
- Zhou, Dian;
- Shen, Ziyuan;
- Zhang, Jiaoli;
- Li, Ping;
- Liang, Aibin;
- Zhou, Keshu;
- Han, Lu;
- Hu, Yongxian;
- Yang, Yun;
- Cao, Jiang;
- Li, Zhenyu;
- Xu, Kailin;
- Sang, Wei
Publication type:
Article
Zanubrutinib Monotherapy for Naïve and Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Pooled Analysis of Three Studies.
Published in:
2022
By:
- Xu, Wei;
- Yang, Shenmiao;
- Tam, Constantine S.;
- Seymour, John F.;
- Zhou, Keshu;
- Opat, Stephen;
- Qiu, Lugui;
- Sun, Mingyuan;
- Wang, Tingyu;
- Trotman, Judith;
- Pan, Ling;
- Gao, Sujun;
- Zhou, Jianfeng;
- Zhou, Daobin;
- Zhu, Jun;
- Song, Yuqin;
- Hu, Jianda;
- Feng, Ru;
- Huang, Haiwen;
- Su, Dan
Publication type:
journal article
Efficacy and Safety of the Biosimilar IBI301 Plus Standard CHOP (I-CHOP) in Comparison With Rituximab Plus CHOP (R-CHOP) in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL): A Randomized, Double-Blind, Parallel-Group, Phase 3 Trial.
Published in:
2021
By:
- Song, Yuqin;
- Zhou, Hui;
- Zhang, Huilai;
- Liu, Wei;
- Shuang, Yuerong;
- Zhou, Keshu;
- Lv, Fangfang;
- Xu, Hao;
- Zhou, Jianfeng;
- Li, Wei;
- Wang, Huaqing;
- Zhang, Hongyu;
- Huang, Haiwen;
- Zhang, Qingyuan;
- Xu, Wei;
- Ge, Zheng;
- Xiang, Ying;
- Wang, Shuye;
- Gao, Da;
- Yang, Shun'e
Publication type:
journal article
MiRNA-223-3p Affects Mantle Cell Lymphoma Development by Regulating the CHUK/NF-ƘB2 Signaling Pathway.
Published in:
OncoTargets & Therapy, 2021, v. 14, p. 1553, doi. 10.2147/OTT.S283486
By:
- Yuan, Jingjing;
- Zhang, Qing;
- Wu, Shengsheng;
- Yan, Suran;
- Zhao, Ran;
- Sun, Yajuan;
- Tian, Xiaoxu;
- Zhou, Keshu
Publication type:
Article

Found: 28